Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Regulators of G protein signaling & drugs of abuse.

Traynor JR, Neubig RR.

Mol Interv. 2005 Feb;5(1):30-41. Review.

PMID:
15734717
2.

Regulator of G protein-signaling proteins and addictive drugs.

Traynor J.

Ann N Y Acad Sci. 2010 Feb;1187:341-52. doi: 10.1111/j.1749-6632.2009.05150.x. Review.

PMID:
20201861
3.
4.

In situ hybridization analysis of RGS mRNA regulation and behavioral phenotyping of RGS mutant mice.

Gold SJ, Zachariou V.

Methods Enzymol. 2004;389:205-29. Review.

PMID:
15313568
5.

Psychostimulants, madness, memory... and RGS proteins?

Burchett SA.

Neuromolecular Med. 2005;7(1-2):101-27. Review.

PMID:
16052041
6.

Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.

Hurst JH, Henkel PA, Brown AL, Hooks SB.

Cell Signal. 2008 Feb;20(2):381-9. Epub 2007 Nov 7.

PMID:
18083345
7.

RGS proteins: new players in the field of opioid signaling and tolerance mechanisms.

Xie GX, Palmer PP.

Anesth Analg. 2005 Apr;100(4):1034-42.

PMID:
15781518
8.

Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein.

Shi J, Damjanoska KJ, Zemaitaitis B, Garcia F, Carrasco G, Sullivan NR, She Y, Young KH, Battaglia G, Van De kar LD, Howland DS, Muma NA.

Neuropharmacology. 2006 Sep;51(3):524-35.

PMID:
16769091
9.

Multi-tasking RGS proteins in the heart: the next therapeutic target?

Riddle EL, Schwartzman RA, Bond M, Insel PA.

Circ Res. 2005 Mar 4;96(4):401-11. Review.

10.

Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.

Garzón J, Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P.

Psychopharmacology (Berl). 2005 Jun;180(1):1-11. Epub 2005 Apr 14. Review.

PMID:
15830230
11.

Regulation of melanin-concentrating hormone receptor 1 signaling by RGS8 with the receptor third intracellular loop.

Miyamoto-Matsubara M, Saitoh O, Maruyama K, Aizaki Y, Saito Y.

Cell Signal. 2008 Nov;20(11):2084-94. doi: 10.1016/j.cellsig.2008.07.019. Epub 2008 Aug 8.

PMID:
18760349
12.
13.

Gene expression induced by drugs of abuse.

Rhodes JS, Crabbe JC.

Curr Opin Pharmacol. 2005 Feb;5(1):26-33. Review.

PMID:
15661622
14.
15.

[RGS proteins (regulators of G protein signaling) and their roles in regulation of immune response].

Lewandowicz AM, Kowalski ML, Pawliczak R.

Postepy Hig Med Dosw (Online). 2004;58:312-20. Review. Polish.

16.

Regulator of G-protein signalling expression and function in ovarian cancer cell lines.

Hurst JH, Mendpara N, Hooks SB.

Cell Mol Biol Lett. 2009;14(1):153-74. doi: 10.2478/s11658-008-0040-7. Epub 2008 Oct 31.

PMID:
18979070
17.
18.

Regulators of G protein signaling: potential drug targets for controlling cardiovascular and immune function.

Cho H, Harrison K, Kehrl JH.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Jun;4(2):107-18. Review.

PMID:
15180451
19.

μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.

Traynor J.

Drug Alcohol Depend. 2012 Mar 1;121(3):173-80. doi: 10.1016/j.drugalcdep.2011.10.027. Epub 2011 Nov 29. Review.

20.

Isolation and characterization of a novel human RGS mutant displaying gain-of-function activity.

Hill C, Brownlie Z, Davey J, Milligan G, Ladds G.

Cell Signal. 2008 Feb;20(2):323-36. Epub 2007 Oct 18.

PMID:
18031991
Items per page

Supplemental Content

Write to the Help Desk